December 2023 Updates

The Faculty and Student Scholarship section is provided as a service to the WSU College of Pharmacy and Pharmaceutical Sciences community for sharing publications, presentations, and other highly transactional types of information. Accuracy of the information presented is the responsibility of those who submitted it. Submissions are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity. Submission for Pharmaceutical Sciences faculty and PhD students can be directed to Kami Ryplewski and submissions for Pharmacotherapy faculty and Doctor of Pharmacy students to Abby Parsons.

Faculty Scholarship

Publications

Esther Lazo (Class of 2023) and Josh Neumiller. Using non-insulin agents to treat or delay type 1 diabetes. Cutting Edge Nutrition and Diabetes Care. 2023;1(2):21-25.

Neumiller JJ and 4 coauthors. Perspectives on chronic kidney disease with type 2 diabetes and risk management: practical viewpoints and a paradigm shift using a pillar approach. Clin Diabetes 2023;41(4):553-566.

Kessel BA, Baker DE. Drug Evaluation – Sotagliflozin (Inpefa).  In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health. October 2023.

Baker DE. Drug Evaluation – Epcoritamab-bysp (Epkinly).  In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health. October 2023.

Baker DE. Drug Evaluation – Glofitamab-gxbm (Columvi).  In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health. October 2023.

Levien TL, Baker DE. Drug Evaluation – Nirsevimab-alip (Beyfortus).  In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health. October 2023.

Levien TL, Baker DE. Drug Evaluation – Respiratory Syncytial Virus Vaccines (Abrysvo & Arexvy).  In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Wolters Kluwer Health. October 2023.

Baker DE. Drug Utilization Evaluation – Nirsevimab-alip (Beyfortus).  In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM).  St. Louis, MO: Clinical Drug Information, LLC. October 2023.

Baker D and 4 coauthors. Impact of pharmacist counseling on treatment adherence outcomes of patients undergoing maintenance hemodialysis. Res J Pharm Tech. 2023;16(9):4384-4390. DOI: 10.52711/0974-360X.2023.00717

John D. Clarke, Sabrina M. Judson, Dan-Dan Tian, Trevor O. Kirby, Rakshit S. Tanna, Adrienn Matula-Péntek, Miklós Horváth, Matthew E. Layton, John R. White, Nadja B. Cech, Kenneth E. Thummel, Jeannine S. McCune, Danny D. Shen, Mary F. Paine. Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants. Clin Transl Sci. 2023; 16: 1779-1790. doi:10.1111/cts.13578

Neumiller JJ and 4 coauthors. Best practices in the use of sodium-glucose cotransporter 2 inhibitors in diabetes and chronic kidney disease for primary care. Diabetology 2023;4:453-464.

Neumiller JJ and 2 coauthors. Incorporating evidence and guidelines for personalized care of diabetes and chronic kidney disease. Semin Nephrol 2023;43(3):151427.

Neumiller JJ and 9 coauthors. Predictors of major adverse kidney disease events in a real-world population with IgA nephropathy. Poster TH-PO614. American Society of Nephrology (ASN) Kidney Week 2023. November 2, 2023.

Neumiller JJ and 12 coauthors. Major adverse kidney disease events in a real-world population with diabetes. Poster SA-PO485. American Society of Nephrology (ASN) Kidney Week 2023. November 4, 2023.

Neumiller JJ and 9 coauthors. Incidence of CKD in prediabetes. Poster SA-PO1095. American Society of Nephrology (ASN) Kidney Week 2023. November 4, 2023.

Presentations

Neumiller JJ. ADA/KDIGO Guidelines Updates: Diabetes Management in CKD. 7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC) Conference. October 21, 2023.

Neumiller JJ. Preserving Kidney Health Outside the Nephrology Clinic. 7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC) Conference. October 21, 2023.

Neumiller JJ. Continuous glucose monitoring: moving beyond A1C for diabetes management. Total Pharmacy Solutions Virtual Summit. October 28, 2023.

Neumiller JJ. Pharmacotherapies for obesity and weight management. 2023 ADCES Solano LNG Diabetes Conference. Fairfield, California. November 4, 2023.

Neumiller JJ. A whole new game: chronic kidney disease. Touro University California 2023 Diabetes Update: High Impact Management for Clinicians. Fairfield, California. November 5, 2023.

Neumiller JJ. Urine the Spotlight Now! A Resurgence in Drug Development and Therapies for CKD. 2023 American College of Clinical Pharmacy (ACCP) Annual Meeting. Dallas, TX. November 13, 2023.

Service

Pharmaceutical Sciences Associate Professor Darrell Jackson was recognized by Provost Elizabeth Chilton for his outstanding contributions on October 14, 2023. Featured Faculty | Office of the Provost | Washington State University (wsu.edu)

Events

Megan Undeberg was invited to share the WWII pharmacists’ stories from her history of pharmacy project/research for the Tadaima 2023 virtual pilgrimage, “Stories of Desperation and Hope: Pharmacists Inside and Outside the WWII Japanese-American Camps.” https://www.jampilgrimages.com/week-3-1

Student Achievement        

Pharmaceutical Sciences and Molecular Medicine students

Shelby Coates Metra (graduate student, Lazarus lab) was selected as the Highlighted Trainee Author for the November 2023 issue in the Journal of Pharmacology and Experimental Therapeutics. The featured article is, “Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions.” ASPET | The Journal of Pharmacology and Experimental Therapeutics Highlighted Trainee Author for the November 2023 Issue

Victoria Oyanna (graduate student, Clarke lab) was selected as the Highlighted Trainee Author for the November 2023 issue in the Drug Metabolism and Disposition journal. The featured article is “Goldenseal-Mediated Inhibition of Intestinal Uptake Transporters Decreases Metformin Systemic Exposure in Mice.” ASPET | Drug Metabolism and Disposition Highlighted Trainee Author for the November 2023 issue